KCT0006457
Recruiting
未知
A single-institution, open, exploratory clinical trial to evaluate the effect of whole-body vibration stimulation treatment on the improvement of bowel function using a sonic whole-body vibrator (SW-VMPROTM) for adults men and women with functional constipation over 20 years of age
ConditionsDiseases of the digestive system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the digestive system
- Sponsor
- Jeonbuk National University Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adult male and female over 20 years of age
- •2\) Those who have had 2 or more of the 6 symptoms presented in the Rome IV constipation assessment criteria for more than 3 months
- •3\) A person who has no communication problems in carrying out and proceeding with the clinical trial
- •4\) A person who fully understands the research purpose and procedure and wishes to participate in clinical research through voluntary consent
Exclusion Criteria
- •1\) Those who do not meet the age criteria
- •2\) Those who have had gastrointestinal surgery within the last 6 months
- •3\) Those with gastrointestinal bleeding, obstructive lesions and open wounds in the abdomen
- •4\) Those who have been taking constipation relievers for 1 month before
- •5\) Those who have dizziness against vibration
- •6\) Pregnant and lactating women
- •7\) Others recognized by the principal investigator as inappropriate to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Single center, therapeutic exploratory clinical trial to evaluate the safety of sodium oxybate (Xyrem) 500 mg/mL oral solution on potential endocrine changes at currently labeled therapeutic dose regimens (4.5 g/day divided into two equal doses)during twelve weeks of treatment of cataplexy in adult patients with narcolepsy. - C00301EUCTR2005-004417-15-BECB Pharma Ltd25
Completed
Phase 1
A SINGLE CENTER, OPEN-LABEL, CLINICAL STUDY TOEVALUATE THE ABILITY OF DERMAL OPEN FLOW MICROPERFUSION (DOFM) FORBIOEQUIVALENCE TESTING OF TOPICALLY APPLIED DICLOFENAC SODIUM PRODUCTSIN HEALTHY SUBJECTSHealthy SubjectsDRKS00023279HEALTH – Institute for Biomedicine and Health Sciences, JOANNEUM RESEARCH Ges.mbH24
Completed
Not Applicable
Systemic exposure study between three formulations of orally inhaled fluticasone propionate and salmeterol xinafoateRespiratoryHealthy subjects, intended disorder is asthmaPACTR201608001741317Circassia Limited24
Completed
Not Applicable
Project on wearable watch for measuring Heart rate, Blood pressure and temperatureHealth Condition 1: R688- Other general symptoms and signsCTRI/2020/06/025988Dr Reddys Laboratories50
Recruiting
Not Applicable
Smart Watch Study for Monitoring Vital SignsHealth Condition 1: R688- Other general symptoms and signsCTRI/2022/04/041899GOQii Technologies Pvt Ltd